These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2748873)

  • 21. Adverse consequences of fluoxetine-MAOI combination therapy.
    Feighner JP; Boyer WF; Tyler DL; Neborsky RJ
    J Clin Psychiatry; 1990 Jun; 51(6):222-5. PubMed ID: 2347858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stroke resulting from a rapid switch from phenelzine to tranylcypromine.
    Mattes JA
    J Clin Psychiatry; 1998 Jul; 59(7):382. PubMed ID: 9714269
    [No Abstract]   [Full Text] [Related]  

  • 23. Phenelzine treatment of melancholia.
    McGrath PJ; Stewart JW; Harrison W; Wager S; Quitkin FM
    J Clin Psychiatry; 1986 Aug; 47(8):420-2. PubMed ID: 3525522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of cocaine abuse with monoamine oxidase inhibitors.
    Brewer C
    Br J Psychiatry; 1993 Dec; 163():815-6. PubMed ID: 8306127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute cardiovascular response to monoamine oxidase inhibitors: a prospective assessment.
    Keck PE; Vuckovic A; Pope HG; Nierenberg AA; Gribble GW; White K
    J Clin Psychopharmacol; 1989 Jun; 9(3):203-6. PubMed ID: 2738182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
    Feighner JP; Herbstein J; Damlouji N
    J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tap (draft) beer and monoamine oxidase inhibitor dietary restrictions.
    Shulman KI; Tailor SA; Walker SE; Gardner DM
    Can J Psychiatry; 1997 Apr; 42(3):310-2. PubMed ID: 9114949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
    Beasley CM; Masica DN; Heiligenstein JH; Wheadon DE; Zerbe RL
    J Clin Psychopharmacol; 1993 Oct; 13(5):312-20. PubMed ID: 8227489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Elderly patients, classical monoamine oxidase inhibitors and intercurrent somatic diseases].
    Oostervink F; Bouvy PF; Touw DJ
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1937-40. PubMed ID: 14574773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan.
    Pope HG; Jonas JM; Hudson JI; Kafka MP
    Am J Psychiatry; 1985 Apr; 142(4):491-2. PubMed ID: 3976924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Not all monoamine oxidase inhibitors are created equal.
    Stewart JT
    J Am Geriatr Soc; 2007 Nov; 55(11):1890. PubMed ID: 17979910
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute psychosis following phenelzine discontinuation.
    Liskin B; Roose SP; Walsh BT; Jackson WK
    J Clin Psychopharmacol; 1985 Feb; 5(1):46-7. PubMed ID: 3973072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoamine oxidase inhibitors in resistant major depression. A double-blind comparison of brofaromine and tranylcypromine in patients resistant to tricyclic antidepressants.
    Nolen WA; Haffmans PM; Bouvy PF; Duivenvoorden HJ
    J Affect Disord; 1993 Jul; 28(3):189-97. PubMed ID: 8408980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brofaromine in treatment-resistant depressed patients--a comparative trial versus tranylcypromine.
    Volz HP; Faltus F; Magyar I; Möller HJ
    J Affect Disord; 1994 Mar; 30(3):209-17. PubMed ID: 8006247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mania associated with high percentage of inhibition of monoamine oxidase.
    Bowden CL; Seleshi E; Javors MA
    Am J Psychiatry; 1989 Jan; 146(1):121. PubMed ID: 2912232
    [No Abstract]   [Full Text] [Related]  

  • 36. Spontaneous hypertensive reactions with monoamine oxidase inhibitors.
    Lavin MR; Mendelowitz A; Kronig MH
    Biol Psychiatry; 1993 Aug; 34(3):146-51. PubMed ID: 8399806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of imipramine-resistant recurrent depression, III: Efficacy of monoamine oxidase inhibitors.
    Thase ME; Frank E; Mallinger AG; Hamer T; Kupfer DJ
    J Clin Psychiatry; 1992 Jan; 53(1):5-11. PubMed ID: 1737741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoinduction of hypertensive reactions by tranylcypromine?
    Keck PE; Pope HG; Nierenberg AA
    J Clin Psychopharmacol; 1989 Feb; 9(1):48-51. PubMed ID: 2486182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parkinsonian side effects induced by a monoamine oxidase inhibitor.
    Teusink JP; Alexopoulos GS; Shamoian CA
    Am J Psychiatry; 1984 Jan; 141(1):118-9. PubMed ID: 6691428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined monoamine oxidase inhibitor-tricyclic antidepressant treatment: a pilot study.
    White K; Pistole T; Boyd JL
    Am J Psychiatry; 1980 Nov; 137(11):1422-5. PubMed ID: 7435677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.